Treating Psoriasis: The Pharmacogenomic Approach

Main Category: Eczema / Psoriasis
Also Included In: Genetics
Article Date: 18 Mar 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (2 votes)

Healthcare Prof:4 stars

4 (1 votes)


This study published in the journal "Dermatology" shows that investigating individual gene characteristics of patients with psoriasis improves the possibilities of pharmacotherapy using pharmacogenomic approaches, which in future could be further stratified according to the subtypes of psoriasis.

A total of 293 patients with plaque psoriasis, 82 patients with psoriasis guttata and 202 control subjects were enrolled in this study. Investigations focused on 3 polymorphisms in retinoid X receptors RXRA and RXRB gene associations. The possible association of their variability with psoriasis was investigated.

A marginally significant increase in AA allelic frequency of the RXRA A39526AA polymorphism in plaque psoriatic men compared to healthy ones was proven. In women with psoriasis guttata, a higher risk for genotypes AA and TT in the RXRB 3'+140A/T polymorphism compared to healthy women was identified. The genotypes A/A and AA/AA were more frequent in plaque psoriasis patients with a positive family history of psoriasis compared to patients with a negative family history of psoriasis. The A/A genotype was more frequent in patients with plaque psoriasis and repeated tonsillitis/tonsillectomy. In the RXRB polymorphism, no genotype TT was observed in patients with psoriasis guttata with a positive personal history of repeated tonsillitis.

Accordingly, these two RXR polymorphisms seem to be susceptibility genes for psoriasis. This knowledge contributes to improving the results of psoriasis therapy using a pharmacogenomic approach.

About S. KARGER AG

With over a century of experience in connecting the world of biomedical science, Karger publishes nearly 80 scientific, peer-reviewed journals and 150 serial and non-serial books and supplement issues annually for a global scientific readership.

S. KARGER AG
Allschwilerstrasse 10
P.O Box
CH-4009 Basel
http://www.karger.com

Article adapted by Medical News Today from original press release.
Visit our eczema / psoriasis section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
James Smith. "Treating Psoriasis: The Pharmacogenomic Approach." Medical News Today. MediLexicon, Intl., 18 Mar. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/65455.php>

APA
James Smith. (2007, March 18). "Treating Psoriasis: The Pharmacogenomic Approach." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/65455.php.

Please note: If no author information is provided, the source is cited instead.




Eczema / Psoriasis

What is Psoriasis?

Psoriasis is a chronic autoimmune disease that mainly affects the skin. It is non-contagious. A reddish, scaly rash - often referred to as red, scaly patches - is commonly found over the surfaces of the scalp, around or in the ears, the elbows, knees... Read more...

Most Popular Articles



Follow Our Eczema News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Eczema / Psoriasis Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »